The current price of 300363.SZ is CN¥24.22 — it has decreased by 3.31% since the previous close. Data as of Nov 6, 2026.
300363.SZ is up 12.55% over the past week, up 3.11% over the past month and down 3.35% over the past year. The price is above its 200-day moving average of CN¥20.17.
Of the 2 analysts covering Porton Pharma Solutions Ltd., 1 rates it a strong buy and 1 rates it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Porton Pharma Solutions Ltd. has a market capitalization of CN¥13B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Porton Pharma Solutions Ltd. posted earnings of CN¥0.22 per share. Upcoming reports are listed in the earnings calendar.
Porton Pharma Solutions Ltd. reported revenue of CN¥983.93M in its most recent quarter, which has increased by 6.54% compared with the same quarter a year earlier. Analysts had expected CN¥983.93M.
Yes. Porton Pharma Solutions Ltd. pays dividends annually. The latest payment of CN¥0.09 per share has a payment date of May 12, 2026, which corresponds to a dividend yield of 0.43%.
In the latest trading session 300363.SZ moved between CN¥21.52 and CN¥24.99, a range of 14.33% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Porton Pharma Solutions Ltd. shows a buy rating today and a strong buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Porton Pharma Solutions Ltd. is buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks 300363.SZ has traded between CN¥13.24 and CN¥30.40. The current price is 20.33% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.